Inspecs Group PLC Ordinary Shares (SPEC)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

82.00p

Buy

82.20p

arrow-down-0.10p (-0.12%)

Prices updated at 12 Dec 2025, 17:32 GMT

Prices minimum 15 mins delay

Prices in GBX

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Instruments & Supplies

Chairman

Mr. Christopher Hancock

CEO

Mr. Richard Peck

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

1,654

Head office

Upper Bristol Road

Bath

United Kingdom

BA1 3AU

+44 1125717000

investor.relations@inspecs.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Christopher Hancock Non-Executive Director, Chairman	-
Ms. Angela Trudie Farrugia Non-Executive Director	-
Mr. Hugo James Adams Non-Executive Director	-
Mr. Christopher Kay Executive Director, Chief Financial Officer	-
Mr. Richard Peck Executive Director, Chief Executive Officer	-
Mr. Robin Bjorn Christian Totterman Executive Director	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Liontrust Investment Partners LLP	8,253,642
Liontrust UK Smaller Companies Fund	8,253,642
Marlborough International Management Limited	7,750,000
Marlborough Special Situations Cell	7,750,000
Hargreave Hale Limited	6,267,478

Director dealings

Date chevron-l-regular chevron-r-regular	Action
No data

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.